These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42 related articles for article (PubMed ID: 3128200)
1. [Metabolism of collagen in coronary patients]. Bonnet J; Aumailley M; Gardères PE; Benchimol D; Moreau C; Brottier L; St Mézard G; Crockett R; Larrue J; Bricaud H Arch Mal Coeur Vaiss; 1987 Oct; 80(11):1577-84. PubMed ID: 3128200 [TBL] [Abstract][Full Text] [Related]
2. [N-terminal peptide of type III procollagen in serum and bronchoalveolar fluid as a marker of collagen metabolism in chronic interstitial lung diseases]. Siemińska A Przegl Lek; 1996; 53(7):574-8. PubMed ID: 8975295 [TBL] [Abstract][Full Text] [Related]
3. Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites. Hørslev-Petersen K; Ammitzbøll T; Engström-Laurent A; Bentsen K; Junker P; Asboe-Hansen G; Lorenzen I J Rheumatol; 1988 Mar; 15(3):460-7. PubMed ID: 3259985 [TBL] [Abstract][Full Text] [Related]
4. Serum levels of extracellular matrix in acute pancreatitis. Löhr M; Hummel F; Martus P; Cidlinsky K; Kröger JC; Hahn EG; Oesterling C; Emmrich J; Schuppan D; Liebe S Hepatogastroenterology; 1999; 46(30):3263-70. PubMed ID: 10626198 [TBL] [Abstract][Full Text] [Related]
5. Mechanical load enhances procollagen processing in dermal fibroblasts by regulating levels of procollagen C-proteinase. Parsons M; Kessler E; Laurent GJ; Brown RA; Bishop JE Exp Cell Res; 1999 Nov; 252(2):319-31. PubMed ID: 10527622 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619 [TBL] [Abstract][Full Text] [Related]
7. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver]. Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314 [TBL] [Abstract][Full Text] [Related]
8. Serological evidence of early remodeling in high-risk non-ST elevation acute coronary syndromes. McGavigan AD; Maxwell PR; Dunn FG Int J Cardiol; 2008 Mar; 125(1):22-7. PubMed ID: 17433479 [TBL] [Abstract][Full Text] [Related]
9. Biochemical markers of types I and III collagen and limited joint mobility in type 1 diabetic patients. Arkkila PE; Koskinen PJ; Kantola IM; Rönnemaa T; Seppänen E; Viikari JS Acta Diabetol; 2003 Dec; 40(4):151-5. PubMed ID: 14740273 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor I and collagen type III synthesis in patients with essential hypertension and left ventricular hypertrophy. Diéz J; Laviades C J Hum Hypertens; 1994 Sep; 8 Suppl 1():S21-5. PubMed ID: 7807509 [TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease. Schuppan D; Besser M; Schwarting R; Hahn EG J Clin Invest; 1986 Jul; 78(1):241-8. PubMed ID: 3722378 [TBL] [Abstract][Full Text] [Related]
12. [Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy]. Niitsu N; Umeda M Rinsho Ketsueki; 1994 Nov; 35(11):1267-75. PubMed ID: 7529840 [TBL] [Abstract][Full Text] [Related]
13. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919 [TBL] [Abstract][Full Text] [Related]
14. Altered protein glycosylation and procollagen to collagen conversion in human fibroblasts. Duksin D; Gal A; Goodman RM Lab Invest; 1983 Sep; 49(3):346-52. PubMed ID: 6887787 [TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease. Bolarin DM; Swerdlow P; Wallace AM; Littsey L Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258 [TBL] [Abstract][Full Text] [Related]
16. The aminoterminal propeptide of type III procollagen and basement membrane components in serum during wound healing in man. Bentsen KD; Lanng C; Hørslev-Petersen K; Risteli J Acta Chir Scand; 1988 Feb; 154(2):97-101. PubMed ID: 3354300 [TBL] [Abstract][Full Text] [Related]
17. Elevated prolidase activity in keloids: correlation with type I collagen turnover. Duong HS; Zhang QZ; Le AD; Kelly AP; Kamdar R; Messadi DV Br J Dermatol; 2006 May; 154(5):820-8. PubMed ID: 16634881 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of the alpha1(I) procollagen gene and up-regulation of alpha1(I) and alpha1(III) procollagen messenger RNA in dermal fibroblasts from tight skin 2 mice. Christner PJ; Hitraya EG; Peters J; McGrath R; Jiménez SA Arthritis Rheum; 1998 Dec; 41(12):2132-42. PubMed ID: 9870870 [TBL] [Abstract][Full Text] [Related]
19. The effect of interferon alpha and prednisolone on the serum concentrations of the aminoterminal domain of procollagen type III(PIIIP) and type IV (7-S collagen) in patients with chronic hepatitis B. Hayasaka A; Kohen H; Yoshikawa N; Iida S; Ohto M J Hepatol; 1993 Aug; 19(1):36-42. PubMed ID: 8301040 [TBL] [Abstract][Full Text] [Related]
20. Serum type III procollagen peptide levels in coronary artery disease (a marker of atherosclerosis). Bonnet J; Garderes PE; Aumailley M; Moreau C; Gouverneur G; Benchimol D; Crockett R; Larrue J; Bricaud H Eur J Clin Invest; 1988 Feb; 18(1):18-21. PubMed ID: 3130254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]